5-fluorodopa has been researched along with dihydroxyphenylalanine in 31 studies
| Studies (5-fluorodopa) | Trials (5-fluorodopa) | Recent Studies (post-2010) (5-fluorodopa) | Studies (dihydroxyphenylalanine) | Trials (dihydroxyphenylalanine) | Recent Studies (post-2010) (dihydroxyphenylalanine) |
|---|---|---|---|---|---|
| 32 | 1 | 5 | 8,823 | 322 | 833 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (22.58) | 18.7374 |
| 1990's | 16 (51.61) | 18.2507 |
| 2000's | 1 (3.23) | 29.6817 |
| 2010's | 7 (22.58) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brooks, DJ; Burn, DJ; Duvoisin, RC; Harding, AE; Maraganore, DM; Mark, MH; Marsden, CD; Playford, ED; Zimmerman, TR | 1 |
| Ido, T; Ishiwata, K; Kubota, K; Kubota, R; Yamada, S | 1 |
| Björklund, A; Brundin, P; Gustavii, B; Langston, JW; Lindvall, O; Rehncrona, S; Snow, B; Tetrud, J; Widner, H | 1 |
| Crouzel, C; Fournier, D; Hantraye, P; Isacson, O; Khalili-Varasteh, M; Loc'H, C; Maziere, B; Riche, D; Stulzaft, O; Yorke, JC | 1 |
| Heiss, WD; Herholz, K; Holthoff, V; Huber, M; Karbe, H; Wagner, R; Wienhard, K | 1 |
| Björklund, A; Bloomfield, PM; Brooks, DJ; Brundin, P; Leenders, KL; Lindvall, O; Marsden, CD; Rehncrona, S; Sawle, GV; Widner, H | 1 |
| Sawle, GV | 1 |
| Fujii, N; Goto, I; Hasuo, K; Hosokawa, S; Ichiya, Y; Kato, M; Kuwabara, Y; Otsuka, M; Taniwaki, T | 1 |
| Argentini, M; Cogoli-Greuter, M; Mäder, T; Weinreich, R; Wiese, C; Winterhalter, KH | 1 |
| Cogoli-Greuter, M; Weinreich, R; Wiese, C; Winterhalter, KH | 2 |
| Calne, DB; Eisen, A; Meneilly, G | 1 |
| Brundin, P; Frackowiak, R; Gustavii, B; Leenders, KL; Lindvall, O; Marsden, CD; Rehncrona, S; Rothwell, JC; Sawle, G; Widner, H | 1 |
| Clark, JC; Firnau, G; Garnett, ES; Jones, T; Leenders, KL; Marsden, CD; Nahmias, C; Palmer, AJ; Quinn, N | 1 |
| Adam, M; Boyes, BE; Cumming, P; Grierson, J; Martin, WR; McGeer, EG; Ruth, T | 1 |
| Frackowiak, RS; Leenders, KL; Lees, AJ | 1 |
| Martin, WR | 1 |
| Firnau, G; Garnett, S; Nahmias, C | 1 |
| Chirakal, R; Firnau, G; Garnett, S; Nahmias, C | 1 |
| Firnau, G; Garnett, S; Pantel, R; Sood, S | 1 |
| Lang, AE | 1 |
| Barrio, JR; Huang, SC; Phelps, ME; Yu, DC | 1 |
| Ashworth, S; Bloomfield, PM; Fricker, RA; Hume, SP; Jones, T; Lammertsma, AA; Myers, R; Rajeswaran, S; Torres, EM; Watson, I | 1 |
| Alanen, K; Bergman, J; Gullichsen, R; Kauhanen, S; Minn, H; Nuutila, P; Parkkola, R; Salmi, J; Salonen, A; Sane, T; Seppänen, M; Solin, O; Välimäki, M | 1 |
| Kuriakose, R; Stoessl, AJ | 1 |
| Piccini, P; Politis, M | 1 |
| Barthlen, W; Mohnike, K; Mohnike, W | 1 |
| Abbs, JH; Bendlin, BB; Brooks, BR; Brown, WD; Chung, MK; Dejesus, OT; Dogan, S; Gallagher, CL; Holden, JE; Johnson, SC; Konopacki, RA; Nickles, RJ; Oakes, TR; Pyzalski, RW; Xu, G | 1 |
| Aizu, K; Fujimaru, R; Hosokawa, Y; Kawakita, R; Masue, M; Matsubara, K; Nagasaka, H; Nishibori, H; Suzuki, S; Yorifuji, T | 1 |
| Consales, A; Garrè, ML; Morana, G; Nozza, P; Piccardo, A; Rossi, A | 1 |
| Alberini, JL; Gauthé, M; Lièvre, A | 1 |
5 review(s) available for 5-fluorodopa and dihydroxyphenylalanine
| Article | Year |
|---|---|
Positron emission tomography in movement disorders.
Topics: Brain; Cerebrovascular Circulation; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Dystonia; Glucose; Humans; Huntington Disease; Levodopa; Movement Disorders; Oxygen Consumption; Parkinson Disease; Synapses; Tomography, Emission-Computed | 1985 |
Hemiatrophy, juvenile-onset exertional alternating leg paresis, hypotonia, and hemidystonia and adult-onset hemiparkinsonism: the spectrum of hemiparkinsonism-hemiatrophy syndrome.
Topics: Antiparkinson Agents; Blood Glucose; Carbidopa; Contrast Media; Deoxyglucose; Dihydroxyphenylalanine; Dominance, Cerebral; Drug Combinations; Female; Fluorodeoxyglucose F18; Functional Laterality; Hemiplegia; Humans; Levodopa; Middle Aged; Muscle Hypotonia; Muscular Atrophy; Neurologic Examination; Parkinson Disease, Secondary; Physical Exertion; Substantia Nigra; Tomography, Emission-Computed | 1995 |
Imaging the nigrostriatal system to monitor disease progression and treatment-induced complications.
Topics: Animals; Biomarkers; Cerebrovascular Circulation; Corpus Striatum; Dihydroxyphenylalanine; Disease Progression; Dopamine; Humans; Magnetic Resonance Imaging; Movement Disorders; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Substantia Nigra; Synapses; Tomography, Emission-Computed, Single-Photon | 2010 |
Brain imaging after neural transplantation.
Topics: Animals; Brain; Brain Tissue Transplantation; Cerebral Cortex; Clinical Trials as Topic; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Dyskinesias; Fetal Tissue Transplantation; Graft Survival; Humans; Nerve Net; Parkinson Disease; Positron-Emission Tomography; Receptors, Presynaptic; Tomography, Emission-Computed, Single-Photon | 2010 |
Techniques in pediatric surgery: congenital hyperinsulinism.
Topics: Anastomosis, Roux-en-Y; Biopsy; Congenital Hyperinsulinism; Dihydroxyphenylalanine; Fluorescent Dyes; Humans; Infant; Jejunum; Laparoscopy; Pancreas; Pancreatic Ducts; Positron-Emission Tomography; Professional Competence; Tomography, X-Ray Computed | 2011 |
1 trial(s) available for 5-fluorodopa and dihydroxyphenylalanine
| Article | Year |
|---|---|
Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adult; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Fetal Tissue Transplantation; Humans; Immunosuppression Therapy; Levodopa; Male; Mesencephalon; Motor Activity; Parkinson Disease, Secondary; Putamen; Stereotaxic Techniques; Time Factors; Tomography, Emission-Computed | 1992 |
25 other study(ies) available for 5-fluorodopa and dihydroxyphenylalanine
| Article | Year |
|---|---|
Parkinson's disease in twins studied with 18F-dopa and positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Brain; Dihydroxyphenylalanine; Diseases in Twins; Fluorine Radioisotopes; Humans; Middle Aged; Parkinson Disease; Tissue Distribution; Tomography, Emission-Computed; Twins, Dizygotic; Twins, Monozygotic | 1992 |
Active melanogenesis in non-S phase melanocytes in B16 melanomas in vivo investigated by double-tracer microautoradiography with 18F-fluorodopa and 3H-thymidine.
Topics: Animals; Autoradiography; Cell Cycle; Dihydroxyphenylalanine; Male; Melanins; Melanocytes; Melanoma, Experimental; Mice; Mice, Inbred C3H; Thymidine | 1992 |
6-[18F]fluoro-L-dopa uptake and [76Br]bromolisuride binding in the excitotoxically lesioned caudate-putamen of nonhuman primates studied using positron emission tomography.
Topics: Animals; Biological Transport; Bromine Radioisotopes; Caudate Nucleus; Dihydroxyphenylalanine; Fluorine Radioisotopes; Ibotenic Acid; Kinetics; Lisuride; Papio; Putamen; Receptors, Dopamine; Receptors, Dopamine D2; Tomography, Emission-Computed | 1992 |
Positron emission tomography in degenerative disorders of the dopaminergic system.
Topics: Adult; Aged; Alzheimer Disease; Basal Ganglia; Brain; Brain Stem; Deoxyglucose; Dihydroxyphenylalanine; Dopamine; Female; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Humans; Male; Middle Aged; Parietal Lobe; Parkinson Disease; Supranuclear Palsy, Progressive; Tomography, Emission-Computed | 1992 |
Transplantation of fetal dopamine neurons in Parkinson's disease: PET [18F]6-L-fluorodopa studies in two patients with putaminal implants.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Brain Tissue Transplantation; Caudate Nucleus; Dihydroxyphenylalanine; Dopamine; Fetal Tissue Transplantation; Humans; Mesencephalon; Models, Biological; Parkinson Disease; Parkinson Disease, Secondary; Putamen; Tomography, Emission-Computed | 1992 |
The rate of progression of Parkinson's disease.
Topics: Adult; Aged; Cell Death; Dihydroxyphenylalanine; Humans; Middle Aged; Parkinson Disease; Reproducibility of Results; Substantia Nigra; Tomography, Emission-Computed | 1992 |
Positron emission tomography (PET) in "pure akinesia".
Topics: Adult; Aged; Brain Chemistry; Dihydroxyphenylalanine; Dopamine; Female; Glucose; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Movement Disorders; Parkinson Disease; Supranuclear Palsy, Progressive; Tomography, Emission-Computed | 1992 |
Metabolism of 5-fluoro-dopa and 6-fluoro-dopa enantiomers in aggregating cell cultures of fetal rat brain.
Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Brain; Cells, Cultured; Dihydroxyphenylalanine; Female; Fetus; Levodopa; Rats; Rats, Inbred Strains; Stereoisomerism; Time Factors | 1992 |
Comparative metabolism of fluorinated 3,4-dihydroxyphenylalanine isomers in aggregating brain cell cultures.
Topics: Animals; Brain; Cell Aggregation; Cells, Cultured; Decarboxylation; Dihydroxyphenylalanine; Levodopa; Methylation; Stereoisomerism | 1992 |
Normal aging of the nervous system.
Topics: Aging; Deoxyglucose; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Intelligence Tests; Nervous System Physiological Phenomena; Reference Values | 1991 |
Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease.
Topics: Brain; Cell Survival; Dihydroxyphenylalanine; Dopamine; Fetus; Fluorine Radioisotopes; Follow-Up Studies; Humans; Immunosuppression Therapy; Mesencephalon; Neurons; Parkinson Disease; Putamen; Tomography, Emission-Computed | 1990 |
Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography.
Topics: Adult; Aged; Brain; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Tomography, Emission-Computed | 1986 |
The metabolism of [18F]6-fluoro-L-3,4-dihydroxyphenylalanine in the hooded rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Caudate Nucleus; Dihydroxyphenylalanine; Hydroxydopamines; Male; Oxidopamine; Rats; Rats, Inbred Strains | 1987 |
Steele-Richardson-Olszewski syndrome. Brain energy metabolism, blood flow and fluorodopa uptake measured by positron emission tomography.
Topics: Adult; Brain; Cerebrovascular Circulation; Dihydroxyphenylalanine; Energy Metabolism; Fluorine Radioisotopes; Humans; Middle Aged; Oxygen Consumption; Supranuclear Palsy, Progressive; Tomography, Emission-Computed | 1988 |
Synthesis of 3,4-dihydroxy-5-fluoro-DL-phenylalanine and 3,4-dihydroxy-5-( 18 F)fluoro-DL-phenylalanine.
Topics: Chromatography, Ion Exchange; Dihydroxyphenylalanine; Fluorine; Half-Life; Isotope Labeling; Methods; Radioisotopes; Spectrophotometry, Infrared | 1973 |
Striatal dopamine metabolism in living monkeys examined by positron emission tomography.
Topics: Animals; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Macaca fascicularis; Radionuclide Imaging | 1983 |
Phenol ionization in dopa determines the site of methylation by catechol-O-methyltransferase.
Topics: Catechol O-Methyltransferase; Dihydroxyphenylalanine; Kinetics; Magnetic Resonance Spectroscopy; Methylation; Phenols | 1981 |
The assessment of the non-equilibrium effect in the 'Patlak analysis' of Fdopa PET studies.
Topics: Blood-Brain Barrier; Brain; Computer Simulation; Dihydroxyphenylalanine; Fluorine Radioisotopes; Humans; Models, Structural; Radiography; Reference Values; Tomography, Emission-Computed | 1995 |
COMT inhibitors and metabolism of fluorodopa enantiomers in aggregating cell cultures.
Topics: Amidines; Animals; Brain; Catechol O-Methyltransferase Inhibitors; Catechols; Cell Aggregation; Cells, Cultured; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Methylation; Pyridones; Rats; Rats, Wistar; Stereoisomerism | 1993 |
The potential of high-resolution positron emission tomography to monitor striatal dopaminergic function in rat models of disease.
Topics: Animals; Carbidopa; Carbon Isotopes; Carrier Proteins; Cerebellum; Dihydroxyphenylalanine; Disease Models, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Huntington Disease; Male; Membrane Glycoproteins; Membrane Transport Proteins; Neostriatum; Nerve Tissue Proteins; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Tomography, Emission-Computed | 1996 |
Fluorine-18-L-dihydroxyphenylalanine (18F-DOPA) positron emission tomography as a tool to localize an insulinoma or beta-cell hyperplasia in adult patients.
Topics: Adult; Dihydroxyphenylalanine; Female; Humans; Hyperplasia; Insulin-Secreting Cells; Insulinoma; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
A longitudinal study of motor performance and striatal [18F]fluorodopa uptake in Parkinson's disease.
Topics: Aged; Aging; Antiparkinson Agents; Carbidopa; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; Female; Hand Strength; Humans; Isometric Contraction; Levodopa; Longitudinal Studies; Male; Middle Aged; Muscle Strength; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Psychomotor Performance; Radiopharmaceuticals; Reaction Time; Retrospective Studies; Sex Characteristics; Tongue | 2011 |
Efficacy and safety of long-term, continuous subcutaneous octreotide infusion for patients with different subtypes of KATP-channel hyperinsulinism.
Topics: ATP-Binding Cassette Transporters; Child Development; Child, Preschool; Congenital Hyperinsulinism; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Humans; Infant; Infant, Newborn; Infusions, Subcutaneous; KATP Channels; Male; Octreotide; Positron-Emission Tomography; Potassium Channels, Inwardly Rectifying; Receptors, Drug; Sulfonylurea Receptors | 2013 |
Multimodal magnetic resonance imaging and 18F-L-dihydroxyphenylalanine positron emission tomography in early characterization of pseudoresponse and nonenhancing tumor progression in a pediatric patient with malignant transformation of ganglioglioma treate
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Cell Transformation, Neoplastic; Child, Preschool; Dacarbazine; Dihydroxyphenylalanine; Disease Progression; Female; Fluorine Radioisotopes; Ganglioglioma; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Temozolomide | 2013 |
Primary Neuroendocrine Tumor in a Horseshoe Kidney With Positive 111In-Pentetreotide Somatostatin Receptor Scintigraphy and Negative 18F-DOPA PET/CT.
Topics: Dihydroxyphenylalanine; Female; Fused Kidney; Humans; Middle Aged; Multimodal Imaging; Neuroendocrine Tumors; Positron-Emission Tomography; Radiopharmaceuticals; Somatostatin; Tomography, X-Ray Computed | 2015 |